Hernandez-Suarez Dagmar F, Ranka Sagar, Villablanca Pedro, Yordan-Lopez Nicole, González-Sepúlveda Lorena, Wiley Jose, Sanina Cristina, Roche-Lima Abiel, Nieves-Rodriguez Brenda G, Thomas Stacey, Cox-Alomar Pedro, Lopez-Candales Angel, Ramakrishna Harish
Division of Cardiovascular Medicine, Department of Medicine, University of Puerto Rico School of Medicine, San Juan, PR, USA.
Department of Medicine, John H Stroger Hospital of Cook County, Chicago, IL, USA.
Cardiovasc Revasc Med. 2019 Jul;20(7):546-552. doi: 10.1016/j.carrev.2019.04.005. Epub 2019 Apr 9.
To identify racial/ethnic disparities in utilization rates, in-hospital outcomes and health care resource use among Non-Hispanic Whites (NHW), African Americans (AA) and Hispanics undergoing transcatheter aortic valve replacement (TAVR) in the United States (US).
The National Inpatient Sample database was queried for patients ≥18 years of age who underwent TAVR from 2012 to 2014. The primary outcome was all-cause in hospital mortality. A total of 36,270 individuals were included in the study. The number of TAVR performed per million population increased in all study groups over the three years [38.8 to 103.8 (NHW); 9.1 to 26.4 (AA) and 9.4 to 18.2 (Hispanics)]. The overall in-hospital mortality was 4.2% for the entire cohort. Race/ethnicity showed no association with in-hospital mortality (P > .05). Though no significant difference were found between AA and NHW in any secondary outcome, being Hispanic was associated with higher incidence of acute myocardial infarction (aOR = 2.02; 95% CI, 1.06-3.85; P = .03), stroke/transient ischemic attack (aOR = 1.81; 95% CI, 1.04-3.14; P = .04), acute kidney injury (aOR = 1.65; 95% CI, 1.23-2.21; P < .01), prolonged length of stay (aOR = 1.18; 95% CI, 1.08-1.29; P < .01) and higher hospital costs (aOR = 1.27; 95% CI, 1.18-1.36; P < .01).
There are significant racial disparities in patients undergoing TAVR in the US. Though in-hospital mortality was not associated with race/ethnicity, Hispanic patients had less TAVR utilization, higher in-hospital complications, prolonged length of stay and increased hospital costs.
确定美国非西班牙裔白人(NHW)、非裔美国人(AA)和西班牙裔人群在接受经导管主动脉瓣置换术(TAVR)时,在利用率、住院结局和医疗资源使用方面的种族/民族差异。
查询2012年至2014年期间接受TAVR的年龄≥18岁患者的全国住院患者样本数据库。主要结局是全因住院死亡率。共有36270人纳入研究。在这三年中,所有研究组每百万人口进行TAVR的数量均有所增加[非西班牙裔白人从38.8增至103.8;非裔美国人从9.1增至26.4;西班牙裔从9.4增至18.2]。整个队列的总体住院死亡率为4.2%。种族/民族与住院死亡率无关联(P>.05)。尽管在任何次要结局方面,非裔美国人和非西班牙裔白人之间未发现显著差异,但西班牙裔人群急性心肌梗死的发生率更高(调整后比值比[aOR]=2.02;95%置信区间[CI],1.06 - 3.85;P=.03)、中风/短暂性脑缺血发作(aOR=1.81;95%CI,1.04 - 3.14;P=.04)、急性肾损伤(aOR=1.65;95%CI,1.23 - 2.21;P<.01)、住院时间延长(aOR=1.18;95%CI,1.08 - 1.29;P<.01)以及住院费用更高(aOR=1.27;95%CI,1.18 - 1.36;P<.01)。
在美国接受TAVR的患者中存在显著的种族差异。尽管住院死亡率与种族/民族无关,但西班牙裔患者TAVR利用率较低、住院并发症较多、住院时间延长且住院费用增加。